AlphaYou
Overview
Smart money at a glance
Filings to Oct 2, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 1- 52-wk high
- $6.25
- 52-wk low
- $0.62
- Mkt cap
- $7.3M
- Beta
- 2.04
- P/S
- 2442.8x
- P/B
- 0.7x
- Profit margin
- +0.0%
- Op margin
- -208004.0%
- ROE
- -77.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CELZ filings
Are insiders buying or selling Creative Medical Technology Holdings Inc (CELZ) stock?
Neither. Creative Medical Technology Holdings Inc (CELZ) insiders filed no open-market purchases or sales in the 90 days to Oct 2, 2026, according to SEC Form 4 filings.
Which members of Congress have traded CELZ recently?
None. No member of Congress disclosed a CELZ trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CELZ smart-money data?
This summary uses filings available on Oct 2, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
2 funds hold a position.
How top traders are positioned
No tracked top-trader positions in CELZ right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 5.1% below what analysts expected.
Earnings per share
-$0.39 expected
Reports Nov 6, 2026, in 35 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $7M
Valuation
- P/S2442.78
- P/B0.71
Quality
- Operating margin-208004.0%
- ROE-77.9%
- ROA-47.3%
Growth
- Beta2.04
Technicals
Price structure
No verified market data for this stock yet.